News
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
3d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results